| Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
|---|---|---|---|---|---|---|
| C18 NEGATIVE ION MODE | FFA(18:0) | 50899537.64 | Peak area normalized | male | Diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 53685945.54 | Peak area normalized | male | Normoglycemic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 56904870.37 | Peak area normalized | male | Pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 57463980.05 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 59016090.92 | Peak area normalized | female | Diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 61083355.59 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 61849354.81 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 62465302.73 | Peak area normalized | female | Diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 63595977.17 | Peak area normalized | male | Diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 63690724.66 | Peak area normalized | male | Diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 64211882.34 | Peak area normalized | male | Normoglycemic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 64904722.18 | Peak area normalized | male | Diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 65587474.16 | Peak area normalized | male | Diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 65809557.54 | Peak area normalized | male | Pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 66622103.14 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 66759663.32 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 66968818.21 | Peak area normalized | female | Diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 67199055.82 | Peak area normalized | female | Diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 67655076.06 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 72947186.59 | Peak area normalized | male | Pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 75708545.47 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 76082651.91 | Peak area normalized | male | Normoglycemic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 76371324.84 | Peak area normalized | male | Pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 80164558.83 | Peak area normalized | male | Diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 90049912.35 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 90767170.35 | Peak area normalized | male | Normoglycemic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 16602 | Peak area normalized | male | Pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 19570 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 23936 | Peak area normalized | male | Normoglycemic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 23994 | Peak area normalized | male | Diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 24881 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 25268 | Peak area normalized | male | Diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 25545 | Peak area normalized | male | Diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 27301 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 28589 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 31608 | Peak area normalized | female | Pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 33603 | Peak area normalized | male | Normoglycemic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 33965 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 37207 | Peak area normalized | male | Diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 37259 | Peak area normalized | male | Pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 38354 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 42689 | Peak area normalized | male | Pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 44075 | Peak area normalized | male | Normoglycemic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 46263 | Peak area normalized | female | Diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 50391 | Peak area normalized | male | Pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 51245 | Peak area normalized | female | Pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 51303 | Peak area normalized | female | Diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 54737 | Peak area normalized | male | Diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 57052 | Peak area normalized | female | Diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 61572 | Peak area normalized | male | Normoglycemic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 67680 | Peak area normalized | male | Diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 108713 | Peak area normalized | female | Diabetic | no neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|